HCA Florida St. Petersburg Hospital performs first aquablation procedure

St. Petersburg, FL — HCA Florida St. Petersburg Hospital is proud to announce the successful completion of its first Aquablation therapy, a cutting-edge, minimally invasive treatment for benign prostatic hyperplasia (BPH), commonly known as enlarged prostate. The procedure was performed by Dr. Rishi Modh, a board-certified urologist and leader in advanced urologic care.

Aquablation therapy combines real-time imaging, robotics and a heat-free waterjet to precisely remove prostate tissue, offering patients a highly customized treatment option with reduced risk of side effects compared to traditional surgical methods.

“This milestone reflects our commitment to bringing innovative, patient-centered solutions to our community,” said Dr. Modh. “Aquablation therapy allows us to treat BPH with greater accuracy and improved outcomes, helping patients return to their normal lives faster.”

Benign prostatic hyperplasia affects millions of men worldwide, often causing urinary symptoms that impact quality of life. Aquablation therapy is designed to address these symptoms while preserving sexual function and minimizing complications.

HCA Florida St. Petersburg Hospital continues to expand its advanced surgical capabilities, ensuring patients have access to the latest technologies and treatments close to home.